Profil
Michael B. Cross is the founder of ARTMS, Inc. Dr. Cross is currently Director at AdipoGenix, Inc., Director at Aegera Therapeutics, Inc., Director at Praxim SA, and Chief Business Officer at Satellos Bioscience, Inc. Formerly, Dr. Cross was Director at Agrisoma Biosciences, Inc., Director at Trillium Therapeutics, Inc. from 2000 to 2012, Director at Viron Therapeutics, Inc., Principal at Nordion (Canada), Inc. from 1996 to 2003, Chief Business Officer at OncoSec Medical, Inc. in 2012, Manager-Investments at Lumira Capital Investment Management, Inc., Senior Vice President & Portfolio Manager at Fairway Capital Management Corp., Principal at TraumaTec, Inc., and Principal at Canada Department of National Defence (Canada).
Dr. Cross earned an MBA and a doctorate from the University of Toronto.
Aktive Positionen von Michael Cross
| Unternehmen | Position | Beginn |
|---|---|---|
| SATELLOS BIOSCIENCE INC. | Corporate Officer/Principal | 01.09.2023 |
AdipoGenix, Inc.
AdipoGenix, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular pharmaceutical products | Direktor/Vorstandsmitglied | - |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs | Direktor/Vorstandsmitglied | 24.09.2009 |
Praxim SA
Praxim SA Medical SpecialtiesHealth Technology Develops and commercializes surgical robots, manual instruments & related software solutions | Direktor/Vorstandsmitglied | 22.10.2009 |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Gründer | - |
Ehemalige bekannte Positionen von Michael Cross
| Unternehmen | Position | Ende |
|---|---|---|
Trillium Therapeutics, Inc. /Old/
Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Direktor/Vorstandsmitglied | - |
| ONCOSEC MEDICAL INCORPORATED | Geschäftsführer | 12.03.2012 |
Fairway Capital Management Corp.
Fairway Capital Management Corp. Investment ManagersFinance Provides investment advisory services | Corporate Officer/Principal | 04.09.2008 |
| NORDION INC | Corporate Officer/Principal | 01.01.2003 |
| ░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Michael Cross
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Nordion (Canada), Inc.
Nordion (Canada), Inc. Medical SpecialtiesHealth Technology Provides cobalt-60 and gamma irradiation system services for the medical device, food safety & health care industries | Health Technology |
AdipoGenix, Inc.
AdipoGenix, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular pharmaceutical products | Health Technology |
OncoSec Medical, Inc.
OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
Fairway Capital Management Corp.
Fairway Capital Management Corp. Investment ManagersFinance Provides investment advisory services | Finance |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Agrisoma Biosciences, Inc.
Agrisoma Biosciences, Inc. Chemicals: SpecialtyProcess Industries Provides crop technology for biofuel and renewable energy solutions | Process Industries |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs | Health Technology |
Trillium Therapeutics, Inc. /Old/
Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Commercial Services |
Praxim SA
Praxim SA Medical SpecialtiesHealth Technology Develops and commercializes surgical robots, manual instruments & related software solutions | Health Technology |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for inflammatory disorders | Health Technology |
TraumaTec, Inc.
TraumaTec, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures medical devices | Electronic Technology |
Canada Department of National Defence (Canada)
Canada Department of National Defence (Canada) SovereignGovernment National Agency | Government |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Satellos Bioscience, Inc.
Satellos Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which is focused on the identification, development and commercialization of drug candidates | Health Technology |
















